Health-Related Quality of Life (Hrqol) During Olaparib Maintenance Therapy in Patients with Platinum-Sensitive Relapsed Serous Ovarian Cancer (Psr Soc) and a Brca Mutation (Brcam)
Year: 2014
Type: article
Source: Annals of Oncology
Authors: J.A. Ledermann, P. Harter, C. Gourley, M. Friedlander, I.B. Vergote, G.J.S. Rustin, C. Scott, W. Meier, R. Shapira-Frommer, T. Safra, D.E. Matei, A. Fielding, S. Spencer, B. Bennett, D. Parry, U. Matulonis
Institutions: Cancer Research UK, University College London, Kliniken Essen-Mitte, Edinburgh Cancer Research, Institute of Genetics and Cancer, UNSW Sydney, Universitair Ziekenhuis Leuven, Mount Vernon Cancer Centre, The Royal Melbourne Hospital, Evangelisches Krankenhaus Düsseldorf, Sheba Medical Center, Tel Aviv Sourasky Medical Center, Indiana University Indianapolis, Indiana University School of Medicine, AstraZeneca (United Kingdom), Dana-Farber Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2345800968